| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 06/08/2000 | WO2000032556A1 Derivatives of (-)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | WO2000032555A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | WO2000032267A2 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | WO2000032235A1 Transport system conjugate |
| 06/08/2000 | WO2000032232A1 Agent containing an additional local anaesthetic for the treatment of symptoms of parkinson's disease |
| 06/08/2000 | WO2000032217A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | WO2000032216A1 Peptoid and nonpeptoid containing alpha-keto oxadiazoles as serine protease inhibitors |
| 06/08/2000 | WO2000032208A2 Isolated material having an anti-organotrophic effect |
| 06/08/2000 | WO2000032195A1 Preparations for intraurethral administration |
| 06/08/2000 | WO2000032187A1 A new pharmaceutical composition |
| 06/08/2000 | WO2000032175A2 METHODS AND COMPOSITIONS FOR RESTORING CONFORMATIONAL STABILITY OF A PROTEIN OF THE p53 FAMILY |
| 06/08/2000 | WO2000032172A1 An oral formulation for gastrointestinal drug delivery |
| 06/08/2000 | WO2000032162A1 Use of plant extracts with an anti-radical-type action |
| 06/08/2000 | WO2000032152A2 Compositions and methods for regulating bacterial pathogenesis |
| 06/08/2000 | WO2000018923A3 Slgp protein and nucleic acid molecule and uses therefor |
| 06/08/2000 | WO2000017228A3 Stereoselective process for enalapril |
| 06/08/2000 | WO2000015245A3 Stable liquid formulations of botulinum toxin |
| 06/08/2000 | WO2000012481A3 Indazole derivatives with 5-ht2 receptor activity________________ |
| 06/08/2000 | WO2000009103A9 N-linked sulfonamides of n-heterocyclic carboxylic acids or isosteres for vision and memory disorders |
| 06/08/2000 | WO2000009086A3 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 06/08/2000 | WO2000007629A3 Peg-urate oxidase conjugates and use thereof |
| 06/08/2000 | WO1999064572A3 Poly(adp-ribose) polymerase gene |
| 06/08/2000 | WO1999058095A3 Pharmaceutical and/or cosmetic compositions containing sea water |
| 06/08/2000 | WO1999024076A9 Salicylate derivatized therapeutic and diagnostic agents |
| 06/08/2000 | DE19832840C1 Mittel zur Immuntherapie von Tumorerkrankungen Means for immunotherapy of tumors |
| 06/08/2000 | CA2353613A1 Preparations for intraurethral administration |
| 06/08/2000 | CA2353602A1 Device for locally delivering a drug in a body cavity |
| 06/08/2000 | CA2353590A1 Isolated material having an anti-organotrophic effect |
| 06/08/2000 | CA2353576A1 Novel nucleic acid transferring agents, compositions containing them and uses |
| 06/08/2000 | CA2353550A1 Small peptides and methods for treatment of asthma and inflammation |
| 06/08/2000 | CA2353521A1 Proteins that bind angiogenesis-inhibiting proteins, compositions and methods of use thereof |
| 06/08/2000 | CA2353394A1 Benzamide derivatives and their use as apob-100 secretion inhibitors |
| 06/08/2000 | CA2353304A1 Polypeptides capable of interacting with the human topoisomerase iii alpha |
| 06/08/2000 | CA2353090A1 Antisense modulation of cellular inhibitor of apoptosis-1 expression |
| 06/08/2000 | CA2353079A1 Gamma-ketoacid tetrapeptides as inhibitors of caspase-3 |
| 06/08/2000 | CA2352555A1 Transport system conjugate |
| 06/08/2000 | CA2352512A1 Lak activity enhancers derived from extract of lentinus endodes mycelium and lak activity-enhancers formulations containing the extract |
| 06/08/2000 | CA2352321A1 Derivatives of (+)-venlafaxine and methods of preparing and using the same |
| 06/08/2000 | CA2351731A1 Compositions and methods for regulating bacterial pathogenesis |
| 06/08/2000 | CA2350597A1 Methods and compositions for restoring conformational stability of a protein of the p53 family |
| 06/08/2000 | CA2349402A1 A new pharmaceutical composition |
| 06/08/2000 | CA2348157A1 Methods and compositions for inhibiting neoplastic cell growth |
| 06/08/2000 | CA2342621A1 8-azabicyclo[3.2.1]oct-2-ene and -octane derivatives |
| 06/07/2000 | EP1005867A2 Botulinum toxins for modulating cholinergic controlled secretions |
| 06/07/2000 | EP1005545A1 Human extracellular matrix-1 |
| 06/07/2000 | EP1005544A1 70 human secreted proteins |
| 06/07/2000 | EP1005539A1 IKK-$g(a) PROTEINS, NUCLEIC ACIDS AND METHODS |
| 06/07/2000 | EP1005488A1 Receptor that binds trail |
| 06/07/2000 | EP1005485A1 Novel pulmonary surfactants and therapeutic uses, including pulmonary lavage |
| 06/07/2000 | EP1005484A1 Compounds with growth hormone releasing properties |
| 06/07/2000 | EP1005480A1 Cytokine-, stress-, and oncoprotein-activated human protein kinase kinases |
| 06/07/2000 | EP1005465A2 New epothilone derivatives, method for producing same and their pharmaceutical use |
| 06/07/2000 | EP1005463A1 Furansulfonic acid derivatives and pharmaceutical compositions containing the same |
| 06/07/2000 | EP1005460A1 Prostaglandin endoperoxide h synthase biosynthesis inhibitors |
| 06/07/2000 | EP1005454A1 2-acylaminopropanamines as tachykinin receptor antagonists |
| 06/07/2000 | EP1005449A1 3-aryl-succinamido-hydroxamic acids, methods for producing said acids and medicaments containing the same |
| 06/07/2000 | EP1005377A2 Receptor-mediated gene delivery using bacteriophage vectors |
| 06/07/2000 | EP1005375A1 Photodynamic therapy generated oxidative stress for temporal and selective expression of heterologous genes |
| 06/07/2000 | EP1005371A2 Method and food product for increasing muscle protein and reducing fat in animals |
| 06/07/2000 | EP1005361A1 USE OF FVIIa OR FVIIai FOR THE TREATMENT OF ADVERSE CONDITIONS RELATED TO THE FVIIa MEDIATED INTRACELLULAR SIGNALLING PATHWAY |
| 06/07/2000 | EP1005360A1 Antioxidant protein 2, gene and methods of use therefor |
| 06/07/2000 | EP1005359A2 FRACTURE HEALING USING PTHrP ANALOGS |
| 06/07/2000 | EP1005356A1 Novel antibacterial agents |
| 06/07/2000 | EP1005354A1 Peptide mimetics of the cytokine receptor gamma chain |
| 06/07/2000 | EP1005351A1 An aqueous metal bicarbonate solution and method of use |
| 06/07/2000 | EP1005348A1 Naaladase compositions and methods for treating glutamate abnormality and effecting neuronal activity in animals |
| 06/07/2000 | EP1005346A2 Solutions containing azasteroids |
| 06/07/2000 | EP1005345A1 Methods and compositions for treating allergic asthma and other disorders using descarboethoxyloratadine |
| 06/07/2000 | EP1005341A1 Il-8 receptor antagonists |
| 06/07/2000 | EP1005340A1 Retinoid antagonists for prevention of surgical adhesions |
| 06/07/2000 | EP1005337A1 Pharmacologic drug combination in vagal-induced asystole |
| 06/07/2000 | EP1005334A1 Neuroprotective compounds and uses thereof |
| 06/07/2000 | EP1005333A1 Methods and compositions for preventing and treating chronological aging in human skin |
| 06/07/2000 | EP1005332A2 Pharmaceutical composition for reducing production of mcp-1 protein |
| 06/07/2000 | EP1005267A1 Phototherapy based method for treating pathogens and composition for effecting same |
| 06/07/2000 | EP0840606B1 Di- and trivalent small molecule selectin inhibitors |
| 06/07/2000 | CN1255919A Efficient enantioselective addition reaction using organozinc reagent |
| 06/07/2000 | CN1255860A Immunogenic compsns to CCK-b/gastrin-receptor and methods for treatment of tumors |
| 06/07/2000 | CN1255854A Use of 1,2,4-triazolo [1,5-C] pyrimidine heterocyclic analogues for prepn. of medicaments useful for treatment of cerebrovascular disturbances |
| 06/07/2000 | CN1255501A Novel phosphonyl sulfonic ester compound and its medicinal compsns. |
| 06/07/2000 | CN1255498A Process for prepn. of growth hormone stimulating secretion agent and its intermediate |
| 06/07/2000 | CN1255493A Novel dihydro and tetrahydro chinoline compounds, its prepn. method and medicinal compsns. |
| 06/07/2000 | CN1255379A Identification method of compound for inhibiting tumour injury and medicinal compsns. containing said compound |
| 06/07/2000 | CN1255376A Method of enhancing crude drugs anti-tumour activity |
| 06/07/2000 | CN1255372A Moxiburning ointment and its preparing process and application |
| 06/07/2000 | CN1053193C Esculetin derivatives, process for manufacture and use thereof, and pharmaceutical compsn. |
| 06/07/2000 | CN1053189C Pyridazino qujinoline compounds |
| 06/07/2000 | CN1053107C Method for preparing vigour strenthening instant powder and Yuan strengthening tablet by using ginseng and scutellaria root |
| 06/07/2000 | CN1053103C Pharmaceutical use of 24-homo-vitamin-D-derivative |
| 06/07/2000 | CN1053102C Application of benzothiophene derivative for medicines of inhibiting cartilage degradation |
| 06/06/2000 | US6072047 Nucleotide and amino acid sequence that binds the protein known as tumor necrosis factor-related apoptosis-inducing ligand; for recombinant expression; for purifying protein or suppressing activities |
| 06/06/2000 | US6072029 Derivatives of human α1 -antitrypsin and process for their preparation |
| 06/06/2000 | US6071970 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 06/06/2000 | US6071968 Phenylenediamine derivative radical scavenger, brain-infarction depressant, and brain-edema depressant |
| 06/06/2000 | US6071956 Treatment of tissues to reduce subsequent response to injury |
| 06/06/2000 | US6071948 Treatment of diseases caused by excessive blood vessel growth |
| 06/06/2000 | US6071942 Elevation of circulating blood histamine levels |
| 06/06/2000 | US6071935 Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use as farnesyl protein transferase inhibitors |
| 06/06/2000 | US6071932 Carbazolypiperines as GABA uptake inhibitors |
| 06/06/2000 | US6071930 Method for treating tumors using 2-aryl-naphthyridin-4-ones |